HPHeidi Paine

Heidi Paine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heidi Paine has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and Reliability of a Competency Assessment Tool for Magnetic Sphincter Augmentation of the Esophagus (MSA CAT) as Part of a Video-based Surgical Quality Assurance Program for the GOLF Trial

    by Nainika Menon, Paul Goldsmith, Richard Owen, Heidi Paine, Maria Bencivenga, Luigi Bonavina, James Gossage, Christian A. Gutschow, Sumeet Mittal, Jessica M. Leers, et al.

    Objective: The development and reliability testing of a video-based competency assessment tool for magnetic sphincter augmentation of the esophagus (MSA CAT). Summary Background Data: Surgical quality assurance (SQA) is the assessment of intraoperative performance by measuring adherence to standardized steps, occurrence of technical errors, and overall technical proficiency. SQA is part of the GOLF trial (ISRCTN: 1353317), an international, multicenter randomized controlled trial (RCT) comparing 2 antireflux procedures, magnetic sphincter augmentation (MSA) and fundoplication. GOLF is the first RCT in which a video-based SQA program was developed with a plan for validation and implementation. Methods: Ten international experts in antireflux surgery participated in a 3-round virtual Delphi consensus process to develop the MSA CAT. To establish interassessor reliability, 6 surgeons reviewed 2 MSA videos. After 3 months, they reviewed the same MSA videos to test intra-assessor reliability using Cohen’s kappa coefficient. Results: Operative steps and key errors were drafted based on the literature. During the 3-round virtual Delphi Consensus amendments to each version were undertaken. Finally, an operative manual and CAT were developed with mandatory, optional, and prohibited steps and quality scores ranging from 1 to 4. The MSA CAT demonstrated good inter- and intra-assessor reliability, particularly when categorizing pairs of scores into “concerning” versus “acceptable.” For interassessor reliability, the mean Cohen’s kappa was 0.785 (0.582–0.892) and 0.827 (0.591–0.912) for each video. For intra-assessor reliability, it was 0.745 (0.717–0.773) and 0.740 (0.510–1.00) for each video. Discussion: This work describes the development and reliability of the novel MSA CAT. This will be further validated by prospective and retrospective video analysis.

  • Open Access

    LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study

    by Heidi Paine, Swathikan Chidambaram, Asif Johar, Nick Maynard, Pernilla Lagergren, Ewen A Griffiths, Paul Behrens, Pritam Singh, Nima Abbassi-Ghadi, Shaun R Preston, et al.

    Background: Long-term symptom burden and health-related quality-of-life outcomes after curative oesophageal cancer treatment are poorly understood. Existing tools are cumbersome and do not address the post-treatment population specifically. The aim of this study was to validate the six-symptom LASORS tool for identifying patients after curative oesophageal cancer treatment with poor health-related quality of life and to assess its clinical utility. Methods: Between 2015 and 2019, patients from 15 UK centres who underwent curative-intent oesophageal cancer treatment, and were disease-free at least 1 year after surgery, were invited to participate in the study and complete LASORS and European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-OG25 questionnaires. Receiver operating characteristic curve analysis was used to examine the accuracy of the LASORS tool for identifying patients with poor health-related quality of life. Results: A total of 263 patients completed the questionnaire. Four of the six LASORS symptoms were associated with poor health-related quality of life: reduced energy (OR 2.13 (95% c.i. 1.45 to 3.13)); low mood (OR 1.86 (95% c.i. 1.20 to 2.88)); diarrhoea more than three times a day unrelated to eating (OR 1.48 (95% c.i. 1.06 to 2.07)); and bloating or cramping after eating (OR 1.35 (95% c.i. 1.03 to 1.77)). The LASORS tool showed good diagnostic accuracy with an area under the receiver operating characteristic curve of 0.858 for identifying patients with poor health-related quality of life. Conclusion: The six-symptom LASORS tool generated a reliable model for identification of patients with poor health-related quality of life after curative treatment for oesophageal cancer. This is the first tool of its kind to be prospectively validated in the post-esophagectomy population. Clinical utility lies in identification of patients at risk of poor health-related quality of life, ease of use of the tool, and in planning survivorship services.